NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/04/2023
Back to search
Official data from USPTO
MP
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000088627756Class
1, 5, 7, 9, 10, 35, 42
Filing
88627756
Registration
7101162
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
01/13/2024
Trademark type
Combined
Nice classes
1, 5, 7, 9, 10, 35, 42
Filing date
09/23/2019
Registration date
07/04/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/04/2023
Last transaction
01/13/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
12/17/2005
First use in commerce
12/17/2005
Drawing code
3
Owner type
16
Owner location
Irvine, CA, US
Examiner
VENGURLEKAR, SAGAR
Law office
M80
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized letters "MP" with square boxes sitting to the right. The designs of a symbolic antibody, fullerene, and double helix appear within the square boxes.
Holders and representatives
Holders
MP BIOMEDICALS, LLC
MP BIOMEDICALS, LLC
Representatives
Jonathan A. Menkes KNOBBE, MARTENS, OLSON & BEAR, LLP
Technical classification
Nice Classes
Class 1Class 5Class 7Class 9Class 10Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Biochemicalsprecursors for in vitro genetic engineering use; Polypeptides for in vitro research use; Monoclonal antibodies for in vitro scientific or research use; Cells for scientificlaboratory or medical research; diagnostic preparations or reagents for scientific research; Diagnostic reagents for in vitro testing in clinical laboratories; Reagents for testing the sterility of medical equipment; Reagents for testing the sterility of pharmaceuticals and injectable solutions; Agentsreagentsassaysenzymesnucleotidesbufferschemical preparationsbiological preparations for scientific and research use; diagnostic reagents and preparationsother than for medical or veterinary use; Kits containing reagents and a protocol for use thereof for non-medical purposes; Agentsreagentsassaysenzymesnucleotidesbufferschemical preparationsbiological preparations for scientific and research usediagnosticsdiagnostic researchclinical researchdrug developmentpharmaceuticalslaboratory researchscientific researchmedical researchlife sciencesbiologymicrobiologybiotechnologyagricultureforensicsfood safetynot for medical or veterinary purposes; Kits comprising nucleotidesreagentsenzyme substratesbufferschemical preparationsbiological preparations for scientific and research use including in the fields of diagnosticsdiagnostic researchclinical researchdrug developmentpharmaceuticalslaboratory researchscientific researchmedical researchlife sciencesbiologymicrobiologybiotechnologyagricultureforensicsfood safetynot for medical or veterinary purposes
Class 5
Cells for medical or clinical use; diagnostic preparations for clinical or medical laboratory use; diagnostic reagents for clinical or medical laboratory use; diagnostic preparations or reagents for medical use; clinical medical reagents; medical diagnostic reagents Agentsreagentsassaysenzymesnucleotidesbufferschemical preparationsbiological preparations for medical use; diagnostic reagents and preparations for medical use; kits containing reagents and a protocol for use thereof for medical purposes; kits comprised of nucleotidesreagentsenzyme substratesbufferschemical preparationsbiological preparations for medical testing and medical diagnostic purposes; agentsreagentsassaysenzymesnucleotidesbufferschemical preparationsbiological preparations for medical use in the fields of medical diagnosticsclinical diagnosticsmedical forensicslaboratory medicine
Class 7
Centrifugal pumps and centrifugal separators; centrifuges
Class 9
Laboratory apparatuscentrifuges; Laboratory consumablespipette tips; Laboratory apparatus and instruments for testing gasliquidssolids; Diagnostic apparatus for the detection of pathogens for laboratory or research use; scientific and laboratory apparatus for use in shaking vessels with a reciprocating motion; Laboratory apparatussample disruption instruments designed to homogenizegrindlyse biological samples
Class 10
Containers for medical waste; Tubes for samplespipette tipspetri dishescollection containers for medical laboratory samplesfilters for medical laboratory usepipettes for medical useall the afore-mentioned goods for medical purposes only; Laboratory articles made of plastic for medical purposes onlycontainerstubes
Class 35
Providing online retail store services featuring a variety of laboratory equipmentkitspreparationsinstruments
Class 42
Product research and development; research and development for new products for others
Publications
History of USPTO decisions and trademark events.
36 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/04/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
06/02/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/01/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/27/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/27/2023
IUAF
USE AMENDMENT FILED
04/10/2023
EISU
TEAS STATEMENT OF USE RECEIVED
04/10/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
10/18/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/23/2022
PUBO
PUBLISHED FOR OPPOSITION
08/23/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/03/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/21/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
07/21/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/21/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
07/21/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/21/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
01/25/2022
GNFR
FINAL REFUSAL E-MAILED
01/25/2022
CNFR
FINAL REFUSAL WRITTEN
01/25/2022
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
01/03/2022
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
06/23/2021
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
12/22/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
06/22/2020
GNSL
LETTER OF SUSPENSION E-MAILED
06/22/2020
CNSL
SUSPENSION LETTER WRITTEN
06/22/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/19/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/18/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/18/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/22/2019
GNRT
NON-FINAL ACTION E-MAILED
12/22/2019
CNRT
NON-FINAL ACTION WRITTEN
12/22/2019
DOCK
ASSIGNED TO EXAMINER
12/22/2019
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
09/28/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/27/2019
NWAP
NEW APPLICATION ENTERED
09/26/2019
Continuous trademark protection
Get notified about every new filing that threatens MP or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.